EuroBiotech: More Articles of Note


> Zealand Pharma began its relocation to a new headquarters. The new site has lab space. Release 

> A journal published phase 2a data on Santhera Pharmaceuticals’ Duchenne muscular dystrophy drug vamorolone. Statement (PDF)

> The Financial Times reported that the U.K. taxman is targeting GlaxoSmithKline contractors. FT


Industry Insight Survey: Direct-to-Patient Distribution of Clinical Supplies

This industry survey seeks to gain insight on trial sponsors' perspective on offering a DTP option and their current level of awareness and understanding of any factors that may influence their ability to do so. The first 50 qualified respondents will receive a $5 Amazon gift card.

> ADC Therapeutics struck a deal to access Freenome’s liquid biopsy platform. Release  

> Boehringer Ingelheim made changes to its leadership team. Statement 

Suggested Articles

Karen DeSalvo's appointment is the latest in a string of hires that deepen the tech giant’s investment in and focus on healthcare.

Spring Bank’s hepatitis B drug, given in tandem with Gilead’s Vemlidy, tamped down on chronic disease in 23% of patients in a phase 2 study.

Gilead names Dickinson to CFO role; MedImmune CSO Herbst nabs CSO job at Pyxis; Checkmate picks up Wooldridge for CMO.